Ultragenyx Pharmaceutical (RARE) News Today $29.92 -0.38 (-1.25%) As of 01:07 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RARE Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE3 hours ago | globenewswire.comUltragenyx Pharmaceutical Inc. $RARE Shares Acquired by Capital Fund Management S.A.August 28 at 4:51 AM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RAREAugust 27 at 10:00 AM | prnewswire.comUltragenyx Pharmaceutical Inc. $RARE Shares Acquired by Price T Rowe Associates Inc. MDAugust 27 at 5:04 AM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RAREAugust 25, 2025 | globenewswire.comRussell Investments Group Ltd. Acquires 34,635 Shares of Ultragenyx Pharmaceutical Inc. $RAREAugust 25, 2025 | marketbeat.comUltragenyx Pharmaceutical (RARE) Valuation Spotlight as DTX401 Gene Therapy Advances With FDA SubmissionAugust 24, 2025 | finance.yahoo.comUltragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives Consensus Recommendation of "Moderate Buy" from AnalystsAugust 24, 2025 | marketbeat.comUltragenyx Pharmaceutical Inc. $RARE Shares Sold by Charles Schwab Investment Management Inc.August 24, 2025 | marketbeat.comCandriam S.C.A. Purchases 53,760 Shares of Ultragenyx Pharmaceutical Inc. $RAREAugust 23, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RAREAugust 22, 2025 | prnewswire.comNuveen LLC Takes $18.78 Million Position in Ultragenyx Pharmaceutical Inc. $RAREAugust 22, 2025 | marketbeat.comUltragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)August 21, 2025 | globenewswire.comWill Ultragenyx’s (RARE) Rolling FDA Submission for DTX401 Reshape Its Rare Disease Narrative?August 21, 2025 | finance.yahoo.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RAREAugust 21, 2025 | globenewswire.comAlgert Global LLC Grows Position in Ultragenyx Pharmaceutical Inc. $RAREAugust 21, 2025 | marketbeat.comAberdeen Group plc Increases Stock Holdings in Ultragenyx Pharmaceutical Inc. $RAREAugust 21, 2025 | marketbeat.comUltragenyx Pharmaceutical Inc.: Ultragenyx Initiates Rolling Submission of Biologics License Application (BLA) to U.S. FDA for DTX401 AAV Gene Therapy for the Treatment of ...August 19, 2025 | finanznachrichten.deUltragenyx Pharmaceutical (NASDAQ:RARE) Shares Acquired Rep. Gilbert Ray Cisneros, Jr.August 19, 2025 | marketbeat.comInvesco Ltd. Reduces Position in Ultragenyx Pharmaceutical Inc. $RAREAugust 19, 2025 | marketbeat.comUltragenyx Initiates Rolling Submission of Biologics License Application (BLA) to U.S. FDA for DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)August 18, 2025 | globenewswire.comConnor Clark & Lunn Investment Management Ltd. Boosts Holdings in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)August 18, 2025 | marketbeat.comUltragenyx Pharmaceutical Inc. (NASDAQ:RARE) Shares Sold by Vanguard Group Inc.August 18, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RAREAugust 17, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RAREAugust 16, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RAREAugust 13, 2025 | globenewswire.comKnott David M Jr Takes $1.74 Million Position in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)August 12, 2025 | marketbeat.comMotley Fool Asset Management LLC Grows Stake in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)August 12, 2025 | marketbeat.comNatixis Advisors LLC Sells 27,404 Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)August 12, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RAREAugust 11, 2025 | prnewswire.comMereo BioPharma Group (MREO) Announced Progress in the Phase 3 Orbit Study Testing UX143August 11, 2025 | msn.comEquities Analysts Issue Forecasts for RARE Q3 EarningsAugust 11, 2025 | marketbeat.comCanaccord Genuity Group Has Lowered Expectations for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock PriceAugust 10, 2025 | marketbeat.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Pacira Pharmaceuticals (PCRX), Ultragenyx Pharmaceutical (RARE) and MoonLake Immunotherapeutics (MLTX)August 9, 2025 | theglobeandmail.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RAREAugust 9, 2025 | globenewswire.comWhat is Wedbush's Estimate for RARE FY2028 Earnings?August 9, 2025 | marketbeat.comCantor Fitzgerald Brokers Cut Earnings Estimates for RAREAugust 9, 2025 | marketbeat.comHC Wainwright Issues Positive Estimate for RARE EarningsAugust 9, 2025 | marketbeat.comLeerink Partnrs Has Positive Estimate for RARE Q3 EarningsAugust 9, 2025 | marketbeat.comWhat is William Blair's Forecast for RARE Q3 Earnings?August 9, 2025 | marketbeat.comUltragenyx (RARE) Q2 Revenue Up 13%August 9, 2025 | theglobeandmail.comUltragenyx Pharmaceutical Inc. (NASDAQ:RARE) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?August 9, 2025 | finance.yahoo.comWilliam Blair Brokers Lower Earnings Estimates for RAREAugust 8, 2025 | marketbeat.comWhat is Leerink Partnrs' Forecast for RARE Q1 Earnings?August 8, 2025 | marketbeat.comUltragenyx Pharmaceutical (NASDAQ:RARE) Given New $105.00 Price Target at Cantor FitzgeraldAugust 7, 2025 | marketbeat.comUltragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | msn.com2RARE : 8 Analysts Assess Ultragenyx Pharmaceutical: What You Need To KnowAugust 6, 2025 | benzinga.comUltragenyx Pharmaceutical (NASDAQ:RARE) Releases Quarterly Earnings Results, Beats Estimates By $0.10 EPSAugust 6, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RAREAugust 6, 2025 | prnewswire.comUltragenyx Completes Enrollment for GTX-102 Phase 3 StudyAugust 6, 2025 | theglobeandmail.com Get Ultragenyx Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for RARE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RARE Media Mentions By Week RARE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RARE News Sentiment▼0.971.03▲Average Medical News Sentiment RARE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RARE Articles This Week▼1110▲RARE Articles Average Week Get the Latest News and Ratings for RARE and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Ultragenyx Pharmaceutical and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Qiagen News Moderna News Verona Pharma PLC American Depositary Share News BridgeBio Pharma News Elanco Animal Health News Roivant Sciences News Grifols News Revolution Medicines News Rhythm Pharmaceuticals News Legend Biotech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RARE) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ultragenyx Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ultragenyx Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access